Related Experiment Video
Updated: Jun 17, 2026

CometChip: A High-throughput 96-Well Platform for Measuring DNA Damage in Microarrayed Human Cells
Published on: October 18, 2014
The effect of Msh2 knockdown on methylating agent induced toxicity in DNA glycosylase deficient cells
N Cooley1, R H Elder, A C Povey
1Centre for Occupational and Environmental Health, School of Community Based Medicine, Faculty of Medical and Human Sciences, University of Manchester, Manchester M139PL, United Kingdom.
Abstract:
The DNA structure recognition protein MSH2 is an important protein in DNA mismatch repair due to its role in initiating the repair process. To examine the potential interactions between mismatch repair and base excision repair (BER) we have examined the effect of MSH2 knockdown on 6-thioguanine (6-TG), temozolomide (TMZ) and methylmethane sulphonate (MMS) induced toxicity in BER proficient and deficient cell lines. An shRNA expression vector containing Msh2 target sequences was designed and used to transfect mouse embryonic fibroblasts lacking either alkylpurine DNA N-glycosylase (Mpg) or endonuclease III homologue (Nth1). Significant knockdown of Msh2 gene expression was achieved with three different target sequences, with the highest level being shown by Msh2(283). Clonal selection resulted in differing levels of knockdown in Mpg(-/-) cells: (69.0+/-12.1% from 5 cell clones). Transfection of the Msh2(283) sequence in Mpg+/+, Nth1+/+ and Nth1(-/-) cells resulted in average knockdowns of 45.1+/-40.5% (3 clones), 58.0+/-21.4% (5 clones) and 74.9+/-14.8% (3 clones), respectively. Msh2 knockdown resulted in increased resistance to 6-TG in BER (MPG and NTH1) proficient and deficient cell lines with similar levels of knockdown (84+/-4%) but increased resistance to TMZ only in Mpg+/+ and Nth1(-/-) cell lines and not Mpg(-/-) or Nth1+/+ cells as assessed by an MTT assay. Msh2 knockdown had no effect on sensitivity to MMS induced toxicity. In a clonogenic assay, Msh2 silenced Mpg+/+, Mpg(-/-), Nth1+/+ and Nth1(-/-) cells were more resistant to TMZ. These results confirm previous studies showing that MSH2 is a key protein in influencing 6-TG and O(6)-methylguanine induced toxicity but also suggest that the effect of this protein depends upon the presence of other proteins in different DNA repair pathways.
Insights
MSH2 knockdown increases resistance to 6-thioguanine (6-TG) and temozolomide (TMZ) in DNA repair deficient cells. The protein MSH2
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- DNA mismatch repair (MMR) protein MSH2 is crucial for DNA repair.
- Interactions between MMR and base excision repair (BER) pathways are not fully understood.
Purpose of the Study:
- To investigate the impact of MSH2 knockdown on cellular sensitivity to DNA damaging agents.
- To explore the interplay between MSH2 and BER pathway components (MPG, NTH1).
Main Methods:
- Utilized shRNA to achieve MSH2 gene knockdown in mouse embryonic fibroblasts.
- Employed MTT and clonogenic assays to assess drug-induced toxicity.
- Generated cell lines deficient in either alkylpurine DNA N-glycosylase (Mpg) or endonuclease III homologue (Nth1).
Main Results:
- MSH2 knockdown conferred resistance to 6-thioguanine (6-TG) across proficient and deficient BER cell lines.
- Resistance to temozolomide (TMZ) upon MSH2 knockdown was observed in specific BER-proficient and deficient contexts.
- MSH2 knockdown did not alter sensitivity to methyl methanesulfonate (MMS).
Conclusions:
- MSH2 plays a significant role in modulating toxicity induced by 6-TG and O(6)-methylguanine.
- The influence of MSH2 on drug sensitivity is dependent on the presence of other DNA repair proteins.
- Findings highlight the complex crosstalk between DNA repair pathways.
More Related Videos
Related Concept Videos
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair
In-vitro Mutagenesis
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation
Spontaneous and Induced Mutations

